Back
MediPharm Labs 10K Form
Sell
29
MEDIF
MediPharm Labs
Last Price:
$0.06
Seasonality Move:
-21.56%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive MEDIF News And Ratings
See the #1 stock for the next 7 days that we like better than MEDIF
MEDIF Financial Statistics
Sales & Book Value
| Annual Sales: | $30.6M |
|---|---|
| Cash Flow: | $-516.2K |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.08 |
| Price / Book: | 0.8 |
Profitability
| EPS (TTM): | -0.02940 |
|---|---|
| Net Income (TTM): | $-8.6M |
| Gross Margin: | $9.3M |
| Return on Equity: | -23.29% |
| Return on Assets: | -18.91% |
MediPharm Labs Earnings Forecast
Key MediPharm Labs Financial Ratios
-
The Gross Profit Margin over the past 7 years for MEDIF is 30.52%.
-
The Selling, General & Administrative Expenses for MEDIF have been equal to 54.47% of Gross Profit Margin.
-
The Research & Development expenses have been 0.56% of Revenue.
-
The Net Earning history of MEDIF is -25.49% of Total Revenues.
-
Per Share Earnings over the last 7 years have been positive in 5 years.
MediPharm Labs Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | OTCM |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | MEDIF |
| Website: | medipharmlabs.com |
Debt
| Debt-to-Equity Ratio: | 0.01 |
|---|---|
| Current Ratio: | 3.21 |
| Quick Ratio: | 1.84 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
MEDIF Technical Analysis vs Fundamental Analysis
Sell
29
MediPharm Labs (MEDIF)
is a Sell
Is MediPharm Labs a Buy or a Sell?
-
MediPharm Labs stock is rated a SellThe current MediPharm Labs [MEDIF] share price is $0.06. The Score for MEDIF is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.